• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞衰老与癌症。

Cellular aging and cancer.

机构信息

Department of Physiology and Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center, San Antonio, TX 78245, USA.

出版信息

Crit Rev Oncol Hematol. 2011 Aug;79(2):189-95. doi: 10.1016/j.critrevonc.2010.07.011. Epub 2010 Aug 11.

DOI:10.1016/j.critrevonc.2010.07.011
PMID:20705476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3033987/
Abstract

Aging is manifest in a variety of changes over time, including changes at the cellular level. Cellular aging acts primarily as a tumor suppressor mechanism, but also may enhance cancer development under certain circumstances. One important process of cellular aging is oncogene-induced senescence, which acts as a significant anti-cancer mechanism. Cellular senescence resulting from damage caused by activated oncogenes prevents the growth of potentially neoplastic cells. Moreover, cells that have entered senescence appear to be targets for elimination by the innate immune system. In another aspect of cellular aging, the absence of telomerase activity in normal tissues results in such cells lacking a telomere maintenance mechanism. One consequence is that in aging there is an increase in cells with shortened telomeres. In the presence of active oncogenes that cause expansion of a neoplastic clone, shortening of telomeres, leading to telomere dysfunction, prevents the indefinite expansion of the clone, because the cells enter crisis. Crisis results from chromosome fusions and other defects caused by dysfunctional telomeres and is a terminal state of the neoplastic clone. In this way the absence of telomerase in human cells, while one cause of cellular aging, also acts as an anti-cancer mechanism.

摘要

衰老是随着时间的推移而表现出的各种变化,包括细胞水平的变化。细胞衰老主要作为一种肿瘤抑制机制,但在某些情况下也可能增强癌症的发展。细胞衰老的一个重要过程是致癌基因诱导的衰老,它作为一种重要的抗癌机制。由激活的致癌基因引起的损伤导致的细胞衰老阻止了潜在的肿瘤细胞的生长。此外,进入衰老状态的细胞似乎成为固有免疫系统消除的目标。在细胞衰老的另一个方面,正常组织中缺乏端粒酶活性导致这些细胞缺乏端粒维持机制。其结果是,随着年龄的增长,端粒缩短的细胞数量增加。在存在导致肿瘤克隆扩张的活跃致癌基因的情况下,端粒缩短导致端粒功能障碍,阻止了克隆的无限扩张,因为细胞进入危机。危机是由功能失调的端粒引起的染色体融合和其他缺陷引起的,是肿瘤克隆的终末状态。通过这种方式,人类细胞中端粒酶的缺失虽然是细胞衰老的一个原因,但也作为一种抗癌机制发挥作用。

相似文献

1
Cellular aging and cancer.细胞衰老与癌症。
Crit Rev Oncol Hematol. 2011 Aug;79(2):189-95. doi: 10.1016/j.critrevonc.2010.07.011. Epub 2010 Aug 11.
2
Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of Telomeres.端粒下游p53对细胞衰老、组织功能及癌症的调控
Cold Spring Harb Perspect Med. 2017 May 1;7(5):a026088. doi: 10.1101/cshperspect.a026088.
3
In vitro aging of rat lung cells. Downregulation of telomerase activity and continuous decrease of telomere length are not incompatible with malignant transformation.大鼠肺细胞的体外老化。端粒酶活性下调和端粒长度持续缩短与恶性转化并非不相容。
Exp Cell Res. 2003 May 15;286(1):30-9. doi: 10.1016/s0014-4827(03)00103-4.
4
Senescence and immortalization: role of telomeres and telomerase.衰老与永生化:端粒和端粒酶的作用
Carcinogenesis. 2005 May;26(5):867-74. doi: 10.1093/carcin/bgh296. Epub 2004 Oct 7.
5
A comparison of oncogene-induced senescence and replicative senescence: implications for tumor suppression and aging.癌基因诱导的衰老与复制性衰老的比较:对肿瘤抑制和衰老的影响。
Age (Dordr). 2014 Jun;36(3):9637. doi: 10.1007/s11357-014-9637-0. Epub 2014 Mar 20.
6
Telomere and telomerase in oncology.肿瘤学中的端粒与端粒酶
Cell Res. 2002 Mar;12(1):1-7. doi: 10.1038/sj.cr.7290104.
7
Telomerase Biology Associations Offer Keys to Cancer and Aging Therapeutics.端粒酶生物学关联为癌症和衰老治疗提供关键线索。
Curr Aging Sci. 2020;13(1):11-21. doi: 10.2174/1874609812666190620124324.
8
[Aging or tumor: the crosstalk between telomerase and p53].衰老还是肿瘤:端粒酶与p53之间的相互作用
Yi Chuan. 2009 May;31(5):451-6. doi: 10.3724/sp.j.1005.2009.00451.
9
Use of U-STELA for Accurate Measurement of Extremely Short Telomeres.使用U-STELA精确测量极短端粒。
Methods Mol Biol. 2019;2045:217-224. doi: 10.1007/7651_2018_120.
10
Telomere length maintenance in aging and carcinogenesis.衰老与致癌过程中的端粒长度维持
Int J Oncol. 2000 Nov;17(5):981-9. doi: 10.3892/ijo.17.5.981.

引用本文的文献

1
Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics.端粒、端粒酶与癌症:作用机制、生物标志物及治疗方法
Exp Hematol Oncol. 2025 Jan 27;14(1):8. doi: 10.1186/s40164-025-00597-9.
2
Cellular Aging and Senescence in Cancer: A Holistic Review of Cellular Fate Determinants.癌症中的细胞衰老与老化:细胞命运决定因素的全面综述
Aging Dis. 2024 May 21;16(3):1483-1512. doi: 10.14336/AD.2024.0421.
3
Telomerase Inhibitor TMPyP4 Alters Adhesion and Migration of Breast-Cancer Cells MCF7 and MDA-MB-231.端粒酶抑制剂 TMPyP4 改变乳腺癌细胞 MCF7 和 MDA-MB-231 的黏附和迁移。

本文引用的文献

1
Telomere lengths in the oral epithelia with and without carcinoma.口腔上皮有癌和无癌组织中的端粒长度。
Eur J Cancer. 2010 Jan;46(2):430-8. doi: 10.1016/j.ejca.2009.10.018. Epub 2009 Nov 10.
2
SASPense and DDRama in cancer and ageing.癌症与衰老中的SASPense和DDRama
Nat Cell Biol. 2009 Aug;11(8):921-3. doi: 10.1038/ncb0809-921.
3
Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells.脂肪基质细胞分泌的白细胞介素6促进乳腺癌细胞的迁移和侵袭。
Int J Mol Sci. 2019 May 30;20(11):2670. doi: 10.3390/ijms20112670.
4
Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse.免疫突触处可溶性和膜结合分子对肿瘤免疫的调节作用。
Clin Dev Immunol. 2013;2013:450291. doi: 10.1155/2013/450291. Epub 2013 Mar 7.
5
Telomeres and tissue engineering: the potential roles of TERT in VEGF-mediated angiogenesis.端粒与组织工程:TERT 在 VEGF 介导的血管生成中的潜在作用。
Stem Cell Rev Rep. 2012 Dec;8(4):1275-81. doi: 10.1007/s12015-012-9414-3.
Oncogene. 2009 Jul 30;28(30):2745-55. doi: 10.1038/onc.2009.130. Epub 2009 Jun 1.
4
Cellular senescence: hot or what?细胞衰老:热门话题还是其他?
Curr Opin Genet Dev. 2009 Feb;19(1):25-31. doi: 10.1016/j.gde.2008.11.009. Epub 2009 Jan 30.
5
Senescence-messaging secretome: SMS-ing cellular stress.衰老信息分泌组:传递细胞应激信号
Nat Rev Cancer. 2009 Feb;9(2):81-94. doi: 10.1038/nrc2560. Epub 2009 Jan 9.
6
ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype.治疗药物通过ATM-ATR依赖性上调多发性骨髓瘤细胞上的DNAM-1和NKG2D配体,导致自然杀伤细胞(NK细胞)易感性增强,并与衰老表型相关。
Blood. 2009 Apr 9;113(15):3503-11. doi: 10.1182/blood-2008-08-173914. Epub 2008 Dec 19.
7
Inflammatory signaling and cellular senescence.炎症信号传导与细胞衰老
Cell Signal. 2009 Mar;21(3):378-83. doi: 10.1016/j.cellsig.2008.10.011. Epub 2008 Oct 26.
8
Cellular senescence: molecular mechanisms, in vivo significance, and redox considerations.细胞衰老:分子机制、体内意义及氧化还原因素
Antioxid Redox Signal. 2009 Jan;11(1):59-98. doi: 10.1089/ars.2008.2104.
9
Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers.了解并利用端粒酶逆转录酶(hTERT)启动子调控用于人类癌症的诊断和治疗。
Cancer Sci. 2008 Aug;99(8):1528-38. doi: 10.1111/j.1349-7006.2008.00878.x.
10
Living on a break: cellular senescence as a DNA-damage response.暂停状态下的生存:细胞衰老作为一种DNA损伤反应
Nat Rev Cancer. 2008 Jul;8(7):512-22. doi: 10.1038/nrc2440.